Halogenated rocaglate derivatives: pan-antiviral agents against hepatitis E virus and emerging virusesShow others and affiliations
2024 (English)In: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 67, no 1, p. 289-321Article in journal (Refereed) Published
Abstract [en]
The synthesis of a library of halogenated rocaglate derivatives belonging to the flavagline class of natural products, of which silvestrol is the most prominent example, is reported. Their antiviral activity and cytotoxicity profile against a wide range of pathogenic viruses, including hepatitis E, Chikungunya, Rift Valley Fever virus and SARS-CoV-2, were determined. The incorporation of halogen substituents at positions 4′, 6 and 8 was shown to have a significant effect on the antiviral activity of rocaglates, some of which even showed enhanced activity compared to CR-31-B and silvestrol.
Place, publisher, year, edition, pages
American Chemical Society (ACS), 2024. Vol. 67, no 1, p. 289-321
National Category
Medicinal Chemistry Microbiology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-220155DOI: 10.1021/acs.jmedchem.3c01357ISI: 001141760200001PubMedID: 38127656Scopus ID: 2-s2.0-85181007683OAI: oai:DiVA.org:umu-220155DiVA, id: diva2:1836825
2024-02-122024-02-122024-02-12Bibliographically approved